other material
confidence high
sentiment positive
materiality 0.35
BioAdaptives partners with Stanford professor to study PluriPain for Gadolinium Deposition Disease pain
BIOADAPTIVES, INC.
- Collaboration with Stanford's Prof. Lorrin Koran to research PluriPain for pain relief in Gadolinium Deposition Disease.
- PluriPain used for analgesic/anti-inflammatory effects; no drug claims are made for treating the disease.
- Gadolinium Deposition Disease is a rare disorder caused by MRI contrast agent, leading to chronic pain.
- BioAdaptives' role is limited to providing PluriPain for Dr. Koran's research.